HB6275 - Protecting Consumer Access to Generic Drugs Act of 2023
US Congress - 118th Congress
Introduced byMarie Gluesenkamp Perez, Sean Casten, Gerald E. Connolly
Last updated 11 months ago
4 Co-Sponsors
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now